/

Batteries & E-Mobility

/

Terumo

Terumo

Terumo

Verified Nov 2026

Batteries & E-Mobility

·

Japan flag

Shibuya, Tokyo

·

Since 1921

Terumo Corporation, headquartered in Shibuya, Tokyo, and founded in 1921, manufactures medical devices and technologies for cardiovascular, blood management, and cell therapy applications. The company operates across automotive, electric-vehicle, medical, and industrial-equipment sectors with an estimated 10,000–50,000 employees and $5–10 billion in annual revenue. In October 2025, Terumo completed the acquisition of OrganOx to expand organ perfusion capabilities.

Terumo

Verified Nov 2026

AT A GLANCE

Founded

1921

Headquarters

Japan flag

Shibuya, Tokyo

Employees

10,000-50,000

Ownership

Terumo at a glance

Revenue

$5-10B

Est. band

Employees

10,000-50,000

Founded

1921

Headquarters

Shibuya, Tokyo

Certifications

ISO 13485

Import activity

2935

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

2935

Named foreign suppliers

47

Top origins

Costa Rica · Guatemala · Colombia · United Kingdom

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Terumo.

What this tells a buyer

Terumo recorded 2,935 customs shipments from 22 countries, with top suppliers including Industrie Borla in Italy (5,587 shipments), Tfb Manufacturing in Costa Rica (1,143 shipments), and Terumo Bct in the United Kingdom (976 shipments).

The company holds ISO 13485 certification and produces coating and assembly solutions across facilities in Leverkusen, Germany, and Michigan.

Terumo operates in over 160 countries and employs approximately 30,689 staff members across its Cardiac and Vascular, General Hospital, and Blood and Cell Technologies divisions.

Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026

STABILITY SIGNALS

Established & active

105 years in operation (founded 1921).

2,935 US import shipments on record.

Holds ISO 13485 certification(s) per public sources.

Overview

Terumo Corporation, headquartered in Shibuya, Tokyo, and founded in 1921, manufactures medical devices and technologies for cardiovascular, blood management, and cell therapy applications. The company operates across automotive, electric-vehicle, medical, and industrial-equipment sectors with an estimated 10,000–50,000 employees and $5–10 billion in annual revenue. In October 2025, Terumo completed the acquisition of OrganOx to expand organ perfusion capabilities.

At a glance

Attribute

Detail

Founded

1921

Headquarters

Shibuya, Tokyo

Employees

10,000-50,000

Revenue

$5-10B (estimated)

Primary capability

Batteries & E-Mobility

Certifications

ISO 13485

What Terumo makes

The company holds ISO 13485 certification and produces coating and assembly solutions across facilities in Leverkusen, Germany, and Michigan.

Products and capabilities described on the company's own site include Coating, Assembly (source: terumo.com).

Certifications

Terumo is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

Terumo recorded 2,935 customs shipments from 22 countries, with top suppliers including Industrie Borla in Italy (5,587 shipments), Tfb Manufacturing in Costa Rica (1,143 shipments), and Terumo Bct in the United Kingdom (976 shipments). US customs bill-of-lading records list 2935 inbound shipments across 47 foreign suppliers, with top origins including Costa Rica · Guatemala · Colombia · United Kingdom.

Latest developments

Facilities

Terumo is headquartered in Shibuya, Tokyo. Public sources also reference these locations:

Company details

Terumo operates in over 160 countries and employs approximately 30,689 staff members across its Cardiac and Vascular, General Hospital, and Blood and Cell Technologies divisions. Terumo was founded in 1921, has an estimated 10,000-50,000 employees, and is headquartered in Shibuya, Tokyo. On the LightSource stability read it is rated "Established & active": 105 years in operation (founded 1921). 2,935 US import shipments on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Terumo make?

Terumo Corporation, headquartered in Shibuya, Tokyo, and founded in 1921, manufactures medical devices and technologies for cardiovascular, blood management, and cell therapy applications. The company operates across automotive, electric-vehicle, medical, and industrial-equipment sectors with an estimated 10,000–50,000 employees and $5–10 billion in annual revenue. In October 2025, Terumo completed the acquisition of OrganOx to expand organ perfusion capabilities.

Where is Terumo headquartered?

Terumo is headquartered in Shibuya, Tokyo.

When was Terumo founded?

Terumo was founded in 1921.

How big is Terumo?

Terumo has an estimated 10,000-50,000 employees, with revenue in the $5-10B range (estimated).

What certifications does Terumo hold?

Terumo lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Does Terumo import from overseas suppliers?

US customs bill-of-lading records show 2935 inbound shipments for Terumo, with top origins including Costa Rica · Guatemala · Colombia · United Kingdom.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Shibuya, Tokyo (HQ)Headquarters · Japan
Shibuya, Tokyo (HQ)Shibuya, Tokyo, 151-0072, JapanHeadquarters

Phone

'+1 800-521-2818

Certification

ISO 13485

Evaluating suppliers like these?

This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.